A prospective observational study of attention-deficit hyperactivity disorder in Asia: Baseline characteristics of symptom severity and treatment options in a paediatric population

East Asian Archives of Psychiatry

Volumn 20, Issue 2, 2010, Pages 76-86

  Martenyi F ^a   Zheng, Y ^a   Huang, Y S ^a   Lee, Y S ^a   Walton, R ^a   Harrison, G ^a   Treuer, T ^a  

^a NONE

Author keywords

Asia; Attention deficit disorder with hyperactivity; Diagnosis; Quality of life; Therapeutics

Indexed keywords

4 AMINOBUTYRIC ACID; CLONIDINE; METHYLPHENIDATE; QUETIAPINE; RISPERIDONE; SERTRALINE;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; ASIA; ATTENTION DEFICIT DISORDER; BRIEF SYMPTOM INVENTORY; CHILD; CHILD BEHAVIOR CHECKLIST; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSYCHOTHERAPY; SCHOOL CHILD;

EID: 77954483700     PISSN: 20789947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 2006;15:13-50.
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8. (Pubitemid 46972911)
3. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104-13.
4. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit / hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007;161:857-64.
5. Gadow KD, Nolan EE, Litcher L, Carlson GA, Panina N, Golovakha E, et al. Comparison of attention-deficit / hyperactivity disorder symptom subtypes in Ukrainian schoolchildren. J Am Acad Child Adolesc Psychiatry 2000;39:1520-7.
6. Gau SS, Chong MY, Chen TH, Cheng AT. A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry 2005;162:1344-50.
7. Takahashi K, Miyawaki D, Suzuki F, Mamoto A, Matsushima N, Tsuji H, et al. Hyperactivity and comorbidity in Japanese children with attention-deficit / hyperactivity disorder. Psychiatry Clin Neurosci 2007;61:255-62.
8. Gau SS, Huang YS, Soong WT, Chou MC, Chou WJ, Shang CY, et al. A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit / hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:447-60.
9. Wang YC, Chong MY, Chou WJ, Yang JL. Prevalence of attention deficit hyperactivity disorder in primary school children in Taiwan. J Formos Med Assoc 1993;92:133-8.
10. Leung PW, Luk SL, Ho TP, Taylor E, Mak FL, Bacon-Shone J. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry 1996;168:486-96. (Pubitemid 26171858)
11. Chae PK, Jung HO, Noh KS. Attention deficit hyperactivity disorder in Korean juvenile delinquents. Adolescence 2001;36:707-25.
12. Mann EM, Ikeda Y, Mueller CW, Takahashi A, Tao KT, Humris E, et al. Cross-cultural differences in rating hyperactive-disruptive behaviors in children. Am J Psychiatry 1992;149:1539-42.
13. Norvilitis JM, Fang P. Perceptions of ADHD in China and the United States: a preliminary study. J Atten Disord 2005;9:413-24.
14. Diagnostic and statistical manual of mental disorders. 4th ed (text revision). Washington, DC: American Psychiatric Press; 2000.
15. Voeller KK. Attention-deficit hyperactivity disorder (ADHD). J Child Neurol 2004;19:798-814.
16. The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines 1992; diagnostic criteria for research 1993. Geneva: World Health Organization; 1993.
17. Lahey BB, Pelham WE, Chronis A, Massetti G, Kipp H, Ehrhardt A, et al. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit / hyperactivity disorder among younger children. J Child Psychol Psychiatry 2006;47:472-9.
18. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-33.
19. Yang L, Wang YF, Qian QJ, Biederman J, Faraone SV. DSM-IV subtypes of ADHD in a Chinese outpatient sample. J Am Acad Child Adolesc Psychiatry 2004;43:248-50.
20. Nolan EE, Gadow KD, Sprafkin J. Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren. J Am Acad Child Adolesc Psychiatry 2001;40:241-9. (Pubitemid 32111029)
21. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit / hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100-7.
22. Hechtman L. Assessment and diagnosis of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:481-98.
23. Ishii T, Takahashi O, Kawamura Y, Ohta T. Comorbidity in attention deficit-hyperactivity disorder. Psychiatry Clin Neurosci 2003;57:457-63.
24. Yang P, Hsu HY, Chiou SS, Chao MC. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Aust N Z J Psychiatry 2007;41:998-1004.
25. Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord 2004;7:163-73.
26. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit / hyperactivity disorder. Pediatrics 2004;114:e541-7.
27. Byun HJ, Yang JW, Lee MS, Jang WS, Yang JW, Kim JH, et al. Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype. Yonsei Med J 2006;47:113-21.
28. Martényi F, Treuer T, Gau SS, Hong SD, Palaczky M, Suba J, et al. Attention-deficit / hyperactivity disorder diagnosis, comorbidities, treatment patterns and quality of life in a pediatric population in central and eastern Europe and Asia. J Child Adolesc Psychopharmacol 2009;19:363-76.
29. Gadow KD, Sprafkin J. Childhood symptom inventory-4 norms / manual. Stony Brook, New York: Checkmate Plus; 2002.
30. Guy W. ECDEU assessment manual for psychopharmacology, revised. Bethesda (MD): US Department of Health, Education and Welfare; 1976.
31. Gadow KD, Sprafkin J. Adolescent symptom inventory 4, screening manual. Stony Brook, New York: Checkmate Plus; 1997.
32. Riley AW, Robertson J, Forrest CB, Green B, Rebok G, Starfield B. Manual for the child health and illness profile - child edition (CHIP-CE). Baltimore, MD: The Johns Hopkins University; 2001.
33. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159:36-42.
34. Quinn P, Wigal S. Perceptions of girls and ADHD: results from a national survey. Med Gen Med 2004;6:2.
35. Chen YF. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology 2002;35:171-5.
36. Pliszka SR. Pharmacologic treatment of attention-deficit / hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychol Rev 2007;17:61-72.
37. Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K; SUNBEAM Study Group. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit / hyperactivity disorder (ADHD). Curr Med Res Opin 2007;23:379-94.
38. Alyhari A, Goodman R. The prevalence of DSM-IV psychiatric disorders among 7-10 year old Yemeni schoolchildren. Soc Psychiatry Psychiatr Epidemiolol 2008;43:224-30. (Pubitemid 351338766)
39. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, et al. Atomoxetine for the treatment of attention-deficit / hyperactivity disorder and oppositional defiant disorder. Pediatrics 2008;121:e314-20.
40. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-77.
41. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord 2007;11:106-13.
42. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guildford Press; 1998.
43. Elia J, Ambrosini P, Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children and adolescents. Child Adolesc Psychiatry Ment Health 2008;2:15.
44. A 14-month randomized clinical trial of treatment strategies for attention-deficit / hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86.
45. Riley AW, Forrest CB, Starfield B, Rebok GW, Robertson JA, Green BF. The Parent Report Form of the CHIP-Child Edition: reliability and validity. Med Care 2004;42:210-20.
46. Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I. Worse quality of life for children with newly diagnosed attention-deficit / hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 2005;116:e364-9.